These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19177313)

  • 61. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of recombinant human erythropoietin and novel erythropoiesis stimulating protein digests by immunoaffinity capillary electrophoresis-mass spectrometry.
    Giménez E; Benavente F; de Bolós C; Nicolás E; Barbosa J; Sanz-Nebot V
    J Chromatogr A; 2009 Mar; 1216(12):2574-82. PubMed ID: 19217628
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ultraperformance liquid chromatography tandem mass spectrometric method for direct quantification of salbutamol in urine samples in doping control.
    Ventura R; Ramírez R; Monfort N; Segura J
    J Pharm Biomed Anal; 2009 Dec; 50(5):886-90. PubMed ID: 19596537
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mass spectrometric determination of insulins and their degradation products in sports drug testing.
    Thevis M; Thomas A; Schänzer W
    Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882
    [TBL] [Abstract][Full Text] [Related]  

  • 67. GASepo-a software solution for quantitative analysis of digital images in Epo doping control.
    Bajla I; Holländer I; Minichmayr M; Gmeiner G; Reichel Ch
    Comput Methods Programs Biomed; 2005 Dec; 80(3):246-70. PubMed ID: 16260062
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New drugs and methods of doping and manipulation.
    Thevis M; Kohler M; Schänzer W
    Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simultaneous detection of xenon and krypton in equine plasma by gas chromatography-tandem mass spectrometry for doping control.
    Kwok WH; Choi TL; So PK; Yao ZP; Wan TS
    Drug Test Anal; 2017 Feb; 9(2):317-322. PubMed ID: 27001214
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug testing.
    Cowan DA
    Essays Biochem; 2008; 44():139-48. PubMed ID: 18384288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry.
    Deventer K; Eenoo PV; Delbeke FT
    Biomed Chromatogr; 2006 May; 20(5):429-33. PubMed ID: 16177960
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS.
    Knoop A; Planitz P; Wüst B; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1666-1672. PubMed ID: 33142033
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analytical aspects in doping control: challenges and perspectives.
    Badoud F; Guillarme D; Boccard J; Grata E; Saugy M; Rudaz S; Veuthey JL
    Forensic Sci Int; 2011 Dec; 213(1-3):49-61. PubMed ID: 21824736
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of EPO injections using a rapid lateral flow isoform test.
    Lönnberg M; Lundby C
    Anal Bioanal Chem; 2013 Dec; 405(30):9685-91. PubMed ID: 23657454
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A new principle suggested for detection of darbepoetin-alpha (NESP) doping.
    Wide L; Wikström B; Eriksson K
    Ups J Med Sci; 2003; 108(3):229-38. PubMed ID: 15000461
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Erythropoiesis stimulating agents and techniques: a challenge for doping analysts.
    Jelkmann W
    Curr Med Chem; 2009; 16(10):1236-47. PubMed ID: 19355882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.